BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30500725)

  • 1. Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrin.
    Anitua E; Nurden P; Prado R; Nurden AT; Padilla S
    Biomaterials; 2019 Feb; 192():440-460. PubMed ID: 30500725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome.
    Anitua E; Prado R; Azkargorta M; Rodriguez-Suárez E; Iloro I; Casado-Vela J; Elortza F; Orive G
    J Tissue Eng Regen Med; 2015 Nov; 9(11):E1-12. PubMed ID: 23505226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized plasma-based medicine to treat age-related diseases.
    Anitua E; Troya M; Zalduendo M; Orive G
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():459-464. PubMed ID: 28254317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-derived biomaterials and platelet growth factors in regenerative medicine.
    Burnouf T; Goubran HA; Chen TM; Ou KL; El-Ekiaby M; Radosevic M
    Blood Rev; 2013 Mar; 27(2):77-89. PubMed ID: 23434399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives.
    Cieslik-Bielecka A; Dohan Ehrenfest DM; Lubkowska A; Bielecki T
    J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):43S-52S. PubMed ID: 23648198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More than 500 million years of evolution in a fibrin-based therapeutic scaffold.
    Anitua E; Nurden P; Nurden AT; Padilla S
    Regen Med; 2020 Apr; 15(4):1493-1498. PubMed ID: 32441555
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth factor content in PRP and their applicability in medicine.
    Lubkowska A; Dolegowska B; Banfi G
    J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):3S-22S. PubMed ID: 23648195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-rich plasma as a scaffold for injectable soft-tissue augmentation.
    Wang P; Qu Y; Man Y
    Cytotherapy; 2010 Sep; 12(5):701-2. PubMed ID: 20491533
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscle repair: platelet-rich plasma derivates as a bridge from spontaneity to intervention.
    Sánchez M; Anitua E; Delgado D; Sánchez P; Orive G; Padilla S
    Injury; 2014 Oct; 45 Suppl 4():S7-14. PubMed ID: 25384475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation.
    Roy S; Driggs J; Elgharably H; Biswas S; Findley M; Khanna S; Gnyawali U; Bergdall VK; Sen CK
    Wound Repair Regen; 2011 Nov; 19(6):753-66. PubMed ID: 22092846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties.
    Anitua E; Zalduendo M; Troya M; Padilla S; Orive G
    PLoS One; 2015; 10(3):e0121713. PubMed ID: 25823008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-rich plasma gel composited with nondegradable porous polyurethane scaffolds as a potential auricular cartilage alternative.
    Wang Z; Qin H; Feng Z; Zhao Y
    J Biomater Appl; 2016 Feb; 30(7):889-99. PubMed ID: 26359295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous liquid platelet rich fibrin: A novel drug delivery system.
    Miron RJ; Zhang Y
    Acta Biomater; 2018 Jul; 75():35-51. PubMed ID: 29772345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of platelet growth factors in treating wounds and soft-tissue injuries.
    Rozman P; Bolta Z
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Dec; 16(4):156-65. PubMed ID: 18204746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healing or Not Healing.
    Padilla S; Sanchez M; Padilla I; Orive G; Anitua E
    Curr Pharm Biotechnol; 2016; 17(5):419-30. PubMed ID: 26956107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-rich plasma to improve the bio-functionality of biomaterials.
    Anitua E; Tejero R; Alkhraisat MH; Orive G
    BioDrugs; 2013 Apr; 27(2):97-111. PubMed ID: 23329397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial.
    Madurantakam P; Yoganarasimha S; Hasan FK
    J Vis Exp; 2015 Sep; (103):. PubMed ID: 26485642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study.
    Alio JL; Rodriguez AE; Martinez LM; Rio AL
    JAMA Ophthalmol; 2013 Jun; 131(6):745-51. PubMed ID: 23559361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological strategies to enhance rotator cuff healing.
    Longo UG; Rizzello G; Berton A; Maltese L; Fumo C; Khan WS; Denaro V
    Curr Stem Cell Res Ther; 2013 Nov; 8(6):464-70. PubMed ID: 24059330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix.
    Han D; Liu W; Ao Q; Wang G
    Med Hypotheses; 2008 Sep; 71(3):374-8. PubMed ID: 18565684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.